These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
16. Rehabilitation in progressive supranuclear palsy: Effectiveness of two multidisciplinary treatments. Clerici I; Ferrazzoli D; Maestri R; Bossio F; Zivi I; Canesi M; Pezzoli G; Frazzitta G PLoS One; 2017; 12(2):e0170927. PubMed ID: 28158197 [TBL] [Abstract][Full Text] [Related]
17. Open-Label Phase 1 Futility Studies of Salsalate and Young Plasma in Progressive Supranuclear Palsy. VandeVrede L; Dale ML; Fields S; Frank M; Hare E; Heuer HW; Keith K; Koestler M; Ljubenkov PA; McDermott D; Ohanesian N; Richards J; Rojas JC; Thijssen EH; Walsh C; Wang P; Wolf A; Quinn JF; Tsai R; Boxer AL Mov Disord Clin Pract; 2020 May; 7(4):440-447. PubMed ID: 32373661 [TBL] [Abstract][Full Text] [Related]
18. A Convenient Prognostic Tool and Staging System for Progressive Supranuclear Palsy. Golbe LI; Ohman-Strickland P; Beisser EB; Elghoul FT Mov Disord Clin Pract; 2020 Aug; 7(6):664-671. PubMed ID: 32775512 [TBL] [Abstract][Full Text] [Related]
19. Association of Progressive Supranuclear Palsy Rating Scale with Progressive Supranuclear Palsy Quality of Life Scale. Pantelyat A; Higginbotham L; Rosenthal L; Lanham D; Nesspor V; AlSalihi M; Bang J; Wang J; Albert M Neurodegener Dis; 2020; 20(4):139-146. PubMed ID: 33789283 [TBL] [Abstract][Full Text] [Related]
20. Liu FT; Lu JY; Li XY; Liang XN; Jiao FY; Ge JJ; Wu P; Li G; Shen B; Wu B; Sun YM; Zhu YH; Luo JF; Yen TC; Wu JJ; Zuo CT; Wang J; Eur J Nucl Med Mol Imaging; 2023 Apr; 50(5):1395-1405. PubMed ID: 36627498 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]